Dow's 17 help Oral Roberts defeat Ecclesia 97-52
Published Dec. 13, 2025 11:15 p.m. ET
Associated Press
TULSA, Okla. (AP) — Connor Dow scored 17 points as Oral Roberts beat Ecclesia 97-52 on Saturday.
Dow went 6 of 12 from the field (4 for 9 from 3-point range) for the Golden Eagles (5-7). Jack Turner finished 5 of 6 from 3-point range to add 15 points. Luke Gray had 13 points and shot 3 of 4 from the field and 7 for 10 from the line.
Christian Ford led the way for the Royals with 11 points. Ecclesia also got 10 points and two steals from Amarion Hoggan. Nate Hauglie finished with five points and two steals.
___
The Associated Press created this story using technology provided by Data Skrive and data from Sportradar.
share
recommended
The New-Look Pac-12 Unveiled a New-Look Logo
2026 College Basketball Transfer Portal Tracker: Oregon Lands Arizona Transfer
Top 25 college athletes with highest NIL valuations
2026 NBA Draft Declarations Tracker: Duke's Cameron Boozer Declares
Ranking the Top 20 Players in the Men's College Basketball Transfer Portal
College Basketball 2025-2026 Buzz: Iowa State, Otzelberger Agree to Massive Deal
Top 10 men's college basketball players with highest NIL valuations
Who are the 10 best Duke basketball players of all time?
What are the 10 most unbreakable records in sports?
Item 1 of 3
recommended
The New-Look Pac-12 Unveiled a New-Look Logo
2026 College Basketball Transfer Portal Tracker: Oregon Lands Arizona Transfer
Top 25 college athletes with highest NIL valuations
2026 NBA Draft Declarations Tracker: Duke's Cameron Boozer Declares
Ranking the Top 20 Players in the Men's College Basketball Transfer Portal
College Basketball 2025-2026 Buzz: Iowa State, Otzelberger Agree to Massive Deal
Top 10 men's college basketball players with highest NIL valuations
Who are the 10 best Duke basketball players of all time?
What are the 10 most unbreakable records in sports?
Item 1 of 3
FOX SPORTS™, SPEED™, SPEED.COM™ & © 2026 Fox Media LLC
and Fox Sports Interactive Media, LLC. All rights reserved. Use of this
website (including any and all parts and components) constitutes your
acceptance of these
Terms of Use and Privacy Policy | Advertising Choices |
Your Privacy Choices | Closed Captioning
